Physician/Medical Officer (GS-14/15)

Division/Office: 

 Division of Therapeutics and Medical Consequences (DTMC) | Clinical/Medical Branch (CMB)

The Division of Therapeutics and Medical Consequences (DTMC), Clinical/Medical Branch (CMB) is hiring a Medical Officer. NIDA’s DTMC takes the lead at the NIH for the support and administration of studies to identify and evaluate the efficacy and/or safety of medications, devices, digital, behavioral, or other therapeutic interventions for the treatment of substance use disorders and to study the medical consequences of drug abuse and addiction.

The CMB has the primary responsibility in DTMC to plans, designs, and implements a comprehensive program that evaluates investigational and marketed medications for their potential value in treating substance abuse disorders through all phases of clinical development (Phases 1-4). CMB also plans, develops, and administers a national and international program of research on medical/clinical/health consequences associated with drugs of abuse (both licit and illicit) and their nexus to co-occurring viral and bacterial infections including HIV, hepatitis, tuberculosis, STIs, and other diseases.  In addition, the CMB supports research training of clinicians and early investigators to expand expertise in research methods as applied to medications development.

As a Medical Officer, you will participate in designing and conducting clinical trials, developing protocols, medical monitoring of clinical trials, providing technical assistance in data analysis, and writing clinical study reports. The Medical Officer provides consultation and collaboration to the pharmaceutical industry, academia, and other interested parties regarding projects of mutual interest, study design, and data analysis. The Division of Therapeutics and Medical Consequences (DTMC), Clinical/Medical Branch (CMB), NIDA is seeking a Medical Officer. The DTMC conducts studies (Phases 1-4) to identify and evaluate the efficacy and/or safety of medications (investigational and marketed), devices, digital, behavioral, or other therapeutic interventions for the treatment of substance use disorders and to study the medical consequences of drug abuse and addiction.  The DTMC also administers a national and international program of research on the medical consequences associated with drugs of abuse (both licit and illicit).

The successful candidate participates in designing and conducting clinical trials, developing protocols, medical monitoring of clinical trials, providing technical assistance in study design and data analysis, writing clinical study reports, designing Data and Safety Monitoring (DSM) Plans, assisting with IND and NDA submissions and reviewing safety reports and providing input at Data and Safety Monitoring Board meetings and Human Research Committee meetings and providing consultation and collaboration to the pharmaceutical industry, academia and the FDA.

Candidates must have a Doctor of Medicine, Doctor of Osteopathic Medicine, or equivalent degree. Candidate must hold an active unrestricted medical license to practice in United States. Candidates with experience in conducting clinical trials, medication drug development, working with pharmaceutical industry, FDA, or IRB are encouraged to apply.

Applications for this vacancy will be accepted through the NIH Global Physician announcement on USAJobs now open: 

Open Monday, June 24, 2024 and will close Wednesday, July 3, 2024, at 11:59 pm EST.  

Extramural Research:

Interested candidates are encouraged to contact Dr. Shwe Gyaw, Chief, Clinical Medical Branch, DTMC, NIDA, at shwe.gyaw@nih.gov  or 301-827-5924.

For more information on DTMC: https://nida.nih.gov/about-nida/organization/divisions/division-therapeutics-medical-consequences-dtmc/clinicalmedical-branch-cm